Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care: the PEDIADEX Randomized Controlled Trial

NCT07542990 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT07542990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07542990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care: the PEDIADEX Randomized Controlled Trial
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 15, 2026
Completion date
August 15, 2029
Enrollment
266 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

delirium in the intensive care unit